These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 19100825)

  • 1. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
    Li XN; Guo HX; Heinamaki J
    J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B; Shun N; Wei X; Wu W
    Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets.
    Alyami H; Koner J; Dahmash EZ; Bowen J; Terry D; Mohammed AR
    J Pharm Pharmacol; 2017 Jul; 69(7):807-822. PubMed ID: 27696423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
    Kumar RV; Sinha VR
    Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
    Li JZ; Rekhi GS; Augsburger LL; Shangraw RF
    Pharm Dev Technol; 1996 Dec; 1(4):343-55. PubMed ID: 9552318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
    Liu L; Xu X
    Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of some compression aids in tableting of roller compacted swellable core drug layer.
    Golchert D; Bines E; Carmody A
    Int J Pharm; 2013 Sep; 453(2):322-8. PubMed ID: 23796839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA; Tripathi R; Mishra B
    AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.